Immune Response News and Research

RSS

Study uncovers an immune evasion mechanism of SARS-CoV-2

Scientists discovered that SARS-CoV-2 can knock out a significant molecular pathway associated with an immune complex named MHC class I.

8 Dec 2021

People previously infected by Chikungunya virus may develop partial immunity to Mayaro virus

A study conducted at the University of São Paulo (USP) in Brazil suggests people previously infected by Chikungunya virus may develop partial immunity to Mayaro virus.

6 Dec 2021

Study analyzes response of individuals from diverse populations to infections

A recent study has identified differences in immune pathway activation to influenza infection between people of European and African genetic ancestry.

2 Dec 2021

Plant-based antiviral treatment found to be effective at treating all SARS-CoV-2 variants

A plant-based antiviral treatment for Covid-19, recently discovered by scientists at the University of Nottingham, has been found to be just as effective at treating all variants of the virus SARS-CoV-2, even the highly infectious Delta variant.

29 Nov 2021

Treatment with common allergy medication linked to improved immunotherapy response

New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated with improved responses to immune checkpoint inhibitors.

29 Nov 2021

Anti-idiotype antibodies may explain the long-term effects of COVID-19

With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field. Researchers are working to find effective vaccines and therapies, as well as understand the long-term effects of the infection.

From The University of California, Davis 26 Nov 2021

Study analyzes connections between COVID-19 severity and gene expression

Recent research reveals how genetic variations associated with severe cases of COVID-19 impact the immune cells.

25 Nov 2021

Researchers expand understanding of how T cells recognize infections or disease

T cells communicate with other cells in the body in search of infections or diseases. This crosstalk relies on specialized receptors known as T cell receptors that recognize foreign molecular fragments from an infection or cancer that are presented for detection by particular molecules called major histocompatibility complex (MHC) or MHC-like.

23 Nov 2021

MIT researchers identify a way to indirectly activate T cells to fight tumors

Under the right circumstances, the body's T cells can detect and destroy cancer cells. However, in most cancer patients, T cells become disarmed once they enter the environment surrounding a tumor.

22 Nov 2021

Covid-19 vaccine-elicited immune cells persist six months after vaccination, study shows

A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination and are at significantly higher levels than for those who are unvaccinated.

17 Nov 2021

CRISPR screening identifies metabolic enzyme as new target for anti-inflammatory therapeutics

A metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inflammatory therapeutics, Vanderbilt researchers have discovered.

12 Nov 2021

Study explores mechanism by which ToBRFV tomato virus overcomes tobamovirus resistance

A new viral tomato disease that broke in the past few years has threatened tomato production across the globe.

8 Nov 2021

'Rewiring' the mitochondria in macrophages can resolve inflammatory reactions

New data from a research team at Friedrich-Alexander-Universität Erlangen-Nürnberg shows how inflammatory reactions can be resolved by changes to the metabolism of macrophages.

8 Nov 2021

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

Monoclonal antibodies protected aged, diabetic rhesus macaque monkeys from disease due to SARS-CoV-2 and reduced signs of inflammation, including in cerebrospinal fluid, according to a new study from researchers at the University of California, Davis.

From The University of California, Davis 2 Nov 2021

Immune Response News and Research

Study uncovers an immune evasion mechanism of SARS-CoV-2

People previously infected by Chikungunya virus may develop partial immunity to Mayaro virus

Study analyzes response of individuals from diverse populations to infections

Plant-based antiviral treatment found to be effective at treating all SARS-CoV-2 variants

Treatment with common allergy medication linked to improved immunotherapy response

Anti-idiotype antibodies may explain the long-term effects of COVID-19

Study analyzes connections between COVID-19 severity and gene expression

Researchers expand understanding of how T cells recognize infections or disease

MIT researchers identify a way to indirectly activate T cells to fight tumors

Covid-19 vaccine-elicited immune cells persist six months after vaccination, study shows

CRISPR screening identifies metabolic enzyme as new target for anti-inflammatory therapeutics

Study explores mechanism by which ToBRFV tomato virus overcomes tobamovirus resistance

'Rewiring' the mitochondria in macrophages can resolve inflammatory reactions

Monoclonal antibodies mitigate inflammatory consequences of SARS-CoV-2 exposure in macaques

Research reveals how foodborne infections protect the gut's nervous system

Study unravels unknown facts about SARS-CoV-2 infection

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Novel genetic biomarkers accurately predict SARS-CoV-2 infection, says study

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Scientists reveal the importance of circadian rhythm on the immune system

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics